Limited Competition for Renewal Applications: Collaborating Centers of Excellence in Regulatory Science and Innovation (U01)
As part of the FDA's Advancing Regulatory Science Initiative, the Office of Chief Scientist supports innovation to improve the development of new tools, standards, and approaches to assess the safety, efficacy, quality, and performance of FDA regulated products. The purpose of this funding opportunity is to provide support for two Collaborating Centers of Excellence in Regulatory Science and Innovation (CERSI) at the University of Maryland, and Georgetown University. The CERSIs will continue to foster an innovative and thematically coherent approach to advance the field of regulatory science (including laboratory, population, behavioral, and manufacturing sciences) and FDA's Advancing Regulatory Science Initiative toward more effective and efficient product development and evaluation.
General information about this opportunity
Last Known Status
Deleted 07/01/2015 (Archived.)
Agency: Department of Health and Human Services
Office: Food and Drug Administration
Type(s) of Assistance Offered
Number of Awards Available
Who is eligible to apply/benefit from this assistance?
Eligibility is limited to the Collaborating Centers of Excellence in Regulatory Science and Innovation (CERSI) at: The University of Maryland and Georgetown University
What is the process for applying and being award this assistance?
Other Assistance Considerations
Formula and Matching Requirements
This program does not have cost sharing or matching requirements.
Who do I contact about this opportunity?
Grants Management Specialist
Range and Average of Financial Assistance
Awards up to $250,000.00